- Home
- IH vs NRXS Comparison
IH vs NRXS Comparison
Compare IH & NRXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | IH | NRXS |
|---|---|---|
| Founded | 1996 | 2011 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | |
| Sector | Real Estate | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 70.5M | 78.9M |
| IPO Year | 2020 | 2023 |
Fundamental Metrics
Financial Performance| Metric | IH | NRXS |
|---|---|---|
| Price | $1.40 | $7.07 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $13.00 |
| AVG Volume (30 Days) | 18.3K | ★ 117.3K |
| Earning Date | 03-31-2026 | 05-12-2026 |
| Dividend Yield | ★ 5.88% | N/A |
| EPS Growth | N/A | ★ 22.13 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,569,282.00 |
| Revenue This Year | N/A | $172.91 |
| Revenue Next Year | N/A | $115.71 |
| P/E Ratio | $7.30 | ★ N/A |
| Revenue Growth | N/A | ★ 32.89 |
| 52 Week Low | $1.33 | $2.20 |
| 52 Week High | $3.60 | $9.33 |
Technical Indicators
Market Signals| Indicator | IH | NRXS |
|---|---|---|
| Relative Strength Index (RSI) | 39.45 | 49.24 |
| Support Level | N/A | $6.79 |
| Resistance Level | $1.84 | $7.79 |
| Average True Range (ATR) | 0.09 | 0.36 |
| MACD | -0.01 | 0.04 |
| Stochastic Oscillator | 15.17 | 73.44 |
Price Performance
Historical ComparisonAbout IH iHuman Inc.
iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources. All of the groups revenue is generated from Chinese Mainland.
About NRXS Neuraxis Inc.
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).